Search results
Vilazodone is a selective serotonin reuptake inhibitor (SSRI) and 5-HT 1A receptor partial agonist approved by the US Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) in adults.
27 lut 2024 · Approach Considerations. Children with small ventricular septal defects (VSDs) are asymptomatic and have an excellent long-term prognosis. Neither medical therapy nor surgical therapy is indicated....
The majority of treatment modes in the management of VSDs and AVSDs are safe and effective and prevent the development of PVOD and cardiac dysfunction. Keywords: Ventricular septal defect, atrioventricular septal defect, surgery, percutaneous treatment, hybrid procedure. Introduction.
This review's first aim is to summarize current pharmacological treatments (both approved and off-label) for panic disorder (PD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and specific phobias (SP), including selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs ...
17 cze 2021 · In this review, the author examines the evidence for psychopharmacologic treatments among adults for generalized anxiety disorder, panic disorder, and social anxiety disorder derived from clinical trials.
28 kwi 2021 · Introduction: The currently accepted psychopharmacological treatment for generalised anxiety disorder in adults is associated with several adverse effects which threaten its acceptability. In this line, vortioxetine has been proposed as an alternative with less adverse effects in the treatment of this pathology.
There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.
